Cargando…

Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis

BACKGROUND: Although the current standard preoperative chemoradiotherapy (PCRT) for stage II/III rectal cancer decreases the risk of local recurrence, it does not improve survival and increases the likelihood of preoperative overtreatment, especially in patients without circumferential resection mar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jii Bum, Kim, Han Sang, Ham, Ahrong, Chang, Jee Suk, Shin, Sang Jun, Beom, Seung-Hoon, Koom, Woong Sub, Kim, Taeil, Han, Yoon Dae, Han, Dai Hoon, Hur, Hyuk, Min, Byung Soh, Lee, Kang Young, Kim, Nam Kyu, Park, Yu Rang, Lim, Joon Seok, Ahn, Joong Bae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848147/ https://www.ncbi.nlm.nih.gov/pubmed/33537238 http://dx.doi.org/10.3389/fonc.2020.609313

Ejemplares similares

Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
por: Lee, Jii Bum, et al.
Publicado: (2020)

Robotic total mesorectal excision for the treatment of rectal cancer
por: Baik, Seung Hyuk, et al.
Publicado: (2007)

Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis
por: Jung, Sung Min, et al.
Publicado: (2016)

Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation
por: Han, Yoon Dae, et al.
Publicado: (2015)

Laparoscopic Total Mesorectal Excision in a Rectal Cancer Patient with Situs Inversus Totalis
por: Huh, Jung Wook, et al.
Publicado: (2010)

Oncologic comparison between nonradical management and total mesorectal excision in good responders after chemoradiotherapy in patients with mid-to-low rectal cancer
por: Lee, Ja Kyung, et al.
Publicado: (2021)

Oncologic Outcomes in Patients Who Undergo Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision for Locally Advanced Rectal Cancer: A 14-Year Experience in a Single Institution
por: Kim, Min Jung, et al.
Publicado: (2019)

Oncologic Impact of Fewer Than 12 Lymph Nodes in Patients Who Underwent Neoadjuvant Chemoradiation Followed by Total Mesorectal Excision for Locally Advanced Rectal Cancer
por: Kim, Woo Ram, et al.
Publicado: (2015)

Transanal Total Mesorectal Excision (TaTME) versus Laparoscopic Total Mesorectal Excision for Lower Rectal Cancer: A Propensity Score-Matched Analysis
por: Lin, Yueh-Chen, et al.
Publicado: (2022)

Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy
por: Koo, Taeryool, et al.
Publicado: (2015)

Introduction to Total Mesorectal Excision
por: Delibegovic, Samir
Publicado: (2017)

Transanal Total Mesorectal Excision for Rectal Cancer: Perioperative and Oncological Outcomes
por: Hur, Hyuk
Publicado: (2018)

Short and Long-Term Outcomes of Robotic versus Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Case-Matched Retrospective Study
por: Cho, Min Soo, et al.
Publicado: (2015)

Local Excision ± Chemoradiotherapy vs. Total Mesorectal Excision for Early Rectal Cancer: Case-Matched Analysis of Long-Term Results
por: Pacevicius, Julius, et al.
Publicado: (2021)

Feasibility of transanal total mesorectal excision in cases with challenging patient and tumor characteristics
por: Sohn, Dae Kyung, et al.
Publicado: (2019)

Comparison of the quality of total mesorectal excision after robotic and laparoscopic surgery for rectal cancer: a multicenter, propensity score-matched study
por: Park, Keehyun, et al.
Publicado: (2021)

Nomogram for prediction of pathologic complete remission using biomarker expression and endoscopic finding after preoperative chemoradiotherapy in rectal cancer
por: Hur, Hyuk, et al.
Publicado: (2020)

Voiding Dysfunction after Total Mesorectal Excision in Rectal Cancer
por: Kim, Jae Heon, et al.
Publicado: (2011)

Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience
por: Kim, Kyung Hwan, et al.
Publicado: (2013)

Reduced-Port Laparoscopic Surgery for a Tumor-Specific Mesorectal Excision in Patients With Colorectal Cancer: Initial Experience With 20 Consecutive Cases
por: Bae, Sung Uk, et al.
Publicado: (2015)

Urinary dysfunction in women following total mesorectal excision versus partial mesorectal excision for treatment of rectal cancer
por: Chill, Henry H., et al.
Publicado: (2021)

Required distal mesorectal resection margin in partial mesorectal excision: a systematic review on distal mesorectal spread
por: Grüter, A. A. J., et al.
Publicado: (2022)

Outcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically T2 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06)
por: Noh, Jae Myoung, et al.
Publicado: (2014)

Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy
por: Solanki, Abhishek A, et al.
Publicado: (2013)

Prognostic Effect of Pretreatment Serum Carcinoembryonic Antigen Level: A Useful Tool for Prediction of Distant Metastasis in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision
por: Kim, Chang Hyun, et al.
Publicado: (2015)

Total mesorectal excision for the treatment of rectal cancer
por: Zedan, Ali, et al.
Publicado: (2015)

Transanal total mesorectal excision: Myths and reality
por: Buchs, Nicolas C, et al.
Publicado: (2016)

Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
por: He, Fang, et al.
Publicado: (2022)

Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
por: Han, Sojung, et al.
Publicado: (2020)

Feasibility of transanal endoscopic total mesorectal excision for rectal cancer: results of a pilot study
por: Oh, Jae Hwan, et al.
Publicado: (2016)

Robotic Total Mesorectal Excision for Rectal Cancer: Current Evidences and Future Perspectives
por: Jang, Je-Ho, et al.
Publicado: (2020)

Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer
por: Shin, Young Seob, et al.
Publicado: (2016)

Simple instruments facilitating achievement of transanal total mesorectal excision in male patients
por: Xu, Chang, et al.
Publicado: (2017)

Association between Fusobacterium nucleatum and patient prognosis in metastatic colon cancer
por: Lee, Jii Bum, et al.
Publicado: (2021)

The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study
por: Akgun, Erhan, et al.
Publicado: (2017)

Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma
por: Cha, Hyejung, et al.
Publicado: (2013)

Transanal total mesorectal excision (TATME) – preliminary findings
por: Piątkowski, Jacek, et al.
Publicado: (2015)

Robotic transanal total mesorectal excision: Is the future now?
por: Sebastián-Tomás, Juan Carlos, et al.
Publicado: (2021)

Update on Robotic Total Mesorectal Excision for Rectal Cancer
por: Giuratrabocchetta, Simona, et al.
Publicado: (2021)

Textbook outcome and survival of robotic versus laparoscopic total gastrectomy for gastric cancer: a propensity score matched cohort study
por: Roh, Chul Kyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_obj9hup0uh1qrg9elcs95jmmjf